ClearNote Health's enhanced Avantect Pancreatic Cancer Test features industry-leading detection sensitivity and specificity ...

Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, ...

Grail Inc.’s multi-cancer blood test, Galleri, failed to hit its primary goal in a large-scale National Health Service trial, ...

A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...

The Primary Endpoint of Statistically Significant Combined Stage III-IV Reduction Was Not Met, However A Favorable Trend Was Observed Over Time GRAIL Announces U.S. Sales Force Expansion Based on ...

Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated in a study published in Communications Medicine. Diagnosing kidney cancer ...

Grail continues facing significant challenges as its stock plummeted over 45% after its landmark NHS-Galleri trial failed to ...

The ‘MYCN’ gene creates a specific nook that turns healthy liver cells into cancer. Detecting MYCN gene early could help identify and reduce liver cancer risk.

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...

Insulin resistance - when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels - ...